Remedent, Inc. (REMI)

[FrankLind]

They are cash flow positive, but revenue might be a little lumpy until the Condor scanner starts to boost sales (and margins). Guy thinks monetization of this concept will be Sept/Oct.

They booked roughly 544,000 revenue from the Biotech deal in that quarter which to a certain extent is an advance payment. I don't think Biotech actually sold that many veneers in that quarter because the deal was only announced on Feb 18th.

If Biotech go through the pre-paid veneer inventory slowly, then this or next quarter will show less revenue from Biotech in the total revenue line.

Revenue from the franchises was about 350,000 (I am unsure as to the makeup of the other portion of revenue)

I think he has to show the core business can be consistently cash flow positive and grow a bit - which allows China to do its thing to boost the stock price.